Health Immune cells in brain could become new drug targets for ASD intellectual disability

Scientists have discovered a convergent mechanism that may be responsible for how two top-ranked genetic risk factors for autism spectrum disorder/intellectual disability (ASD/ID) lead to these neurodevelopmental disorders. While ASD is distinct from ID, a significant proportion approximately 31 per cent of people with ASD also exhibit ID. Neither condition is well-understood at the molecular level.